http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002197620-A1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4703 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4748 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
filingDate | 2002-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54a4733b277b4b3a105b8b3f34cfbf77 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d731bee0fe0858003d4ecdcd214754c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d821ac9302948027f32e3507dfb776f |
publicationDate | 2002-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2002197620-A1 |
titleOfInvention | Tumor marker Zsig62 |
abstract | Studies indicate that mutations in tumor suppressor genes occur early in the process of carcinogenesis, and that these mutations are correlated with a subsequent development of cancer. The detection of such alterations would provide useful molecular markers for diagnosis, surveillance, early tumor identification and intervention, and prognosis. A novel human gene, designated as “Zsig62,” resides within a region of chromosome 16q that is associated with prostate and breast cancer, and that appears to contain tumor suppressor genes. Like a tumor suppressor gene, the Zsig62 gene is expressed in particular normal tissues, but not in tumors derived from those tissues. |
priorityDate | 1999-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 2280.